# US 2013/0096530 A1 · Method of monitoring safety in medication delivery for diabetes management

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0096530 A1
- Document ID: US20130096530A1
- Status: Published application
- Kind: A1
- Application number: 13/645,233
- Filed: 2012-10-04
- Published: 2013-04-18
- Earliest claimed: 2009-05-22
- Assignees: Abbott Diabetes Care Inc.
- Inventors: Erwin S. Budiman
- Web page: https://patentgrep.com/patent/US20130096530A1

## CPC

- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/4839: {combined with drug delivery}
- A61M 5/142: Pressure infusion, e.g. using pumps
- G16H 20/17: delivered via infusion or injection
- G16H 40/67: for remote operation
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- A61M 2005/14208: {with a programmable infusion control system, characterised by the infusion program}
- A61M 2005/14296: {Pharmacokinetic models}
- A61M 2205/17: with redundant control systems
- A61M 2205/3303: Using a biosensor
- A61M 2205/3569: sublocal, e.g. between console and disposable
- A61M 2205/50: with microprocessors or computers
- A61M 2205/52: with memories providing a history of measured variating parameters of apparatus or patient
- A61M 2205/702: automatically during use
- A61M 2230/201: Glucose concentration
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Glucose sensor signals and medication delivery control signals are monitored and these signals are modified for compatibility and safety purposes. In one application, output control signals from a controller directed to a delivery device are modified as a function of an actual amount of insulin delivered to the user. The safety layer method allows for an increased level of safety in an integrated delivery management (“IDM”) system and permits the development of separate hardware and software upgrades for components of the IDM system while assuring that compatibility between components will continue and safety is increased.

## Claims

### Claim at position 1

1-23. (canceled)

### Claim 24

A method of diabetes management, comprising:
sensing glucose and providing sensor glucose data representative of sensed glucose;
delivering medication in response to a delivery control signal;
receiving glucose data and providing an output control signal as a function of the received glucose data;
monitoring the amount of medication delivered; and
receiving at least one of the sensor glucose data and the output control signal, and modifying at least one of the sensor glucose data and the output control signal;
wherein the glucose data would be modified to become modified glucose data;
wherein the output control signal would be modified to become a modified output control signal;
communicating the modified output control signal as the delivery control signal; and
wherein modifying at least one of the glucose data and the output control signal includes modifying as a function of the monitored amount of medication delivered.

### Claim 25 (depends on 24)

The method of diabetes management of claim 24, further comprising:
calculating the output control signal; and
intercepting the output control signal and substituting the modified control signal as the delivery control signal without reconfiguring the step of calculating the output control signal or the step of communicating a delivery control signal.

### Claim 26 (depends on 24)

The method of diabetes management of claim 24, further comprising:
safety monitoring the sensor glucose data between the steps of providing sensor glucose data and receiving glucose data; and
separately safety monitoring the output control signal.

### Claim 27 (depends on 26)

The method of diabetes management of claim 26, wherein the step of separately safety monitoring the output control signal further comprises also providing feedback to the safety monitoring of the sensor glucose data step.

### Claim 28 (depends on 27)

The method of diabetes management of claim 27, wherein the step of providing feedback comprises providing feedback as a function of a limit on the delivery of medication and on the modified output control signal; and
wherein the step of modifying glucose data further includes modifying glucose data as a function of the feedback.
